Knockdown or CRISPR/Cas9-mediated knockout of CDK7 results in reduced cell proliferation of gastric cancer and triple-negative breast cancer cells, respectively, highlighting a functional role of CDK7 in tumor cell growth [21,22]. Here, CDK7 is linked to neoplasm.